A woman gets a mammogram. All U.S. women getting mammograms will soon receive information about their breast density, which can sometimes make cancer harder to spot. The new requirements, finalized Thursday by the Food and Drug Administration, are aimed at standardizing the informa...
Federal Drug Administration officials have released new standards to help women detect breast cancer earlier. Mammogram providers will now be required to inform women if they have dense breast tissue. Dr. Jessica Shepherd, chief medical officer for Veryw
In September 2024, new guidelines from the Food and Drug Administration (FDA) will require that all women receive information about their breast density following a mammogram. This change aims to empower women with more knowledge about their breast health, but the new information could also cause ...
Higher breast density alone isn’t necessarily something to worry about. According to the FDA, half of women over 40 in the U.S. have dense breast tissue. These new rules will require mammogram providers to notify women if they have dense breast tissue and recommend they consult with a doct...
What does the new FDA rule say? The FDA now requires specific language to ensure that all women receive the same "accurate, complete and understandable breast density information." After a mammogram, women must be informed: • Whether their breasts are dense or not dense ...
Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics. October 18th 2024 Muscle-Directed Therapy Apitegromab Meets Primary End Point in Phase 3 SAPPHIRE...
Click to email a link to a friend (Opens in new window) Like this: Loading... Read Full Post » Automated Breast Ultrasound System (‘ABUS’) for full breast scanning: The beginning of structuring a solution for an acute need!
(HealthDay)—A new test marketed as an alternative to a mammogram for breast cancer detection is not an effective screening TOOL, U.S. health officials say.
An expert FDA advisory committee has voted unanimously to expand the use of automated breast ultrasound as a screening tool for women with dense breast tissue.